Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 3 , Pages 287-297 , September 2009

Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo

Received 22 August 2008 ,Accepted 22 December 2008.

References 

  1. Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 2002;9:1647–1652
  2. Jolly D. Viral vector systems for gene therapy. Cancer Gene Ther. 1994;1:51–64
  3. Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev. 2002;54:715–758
  4. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov. 2005;4:581–593
  5. Dufès C, Keith WN, Bilsland A, Proutski I, Uchegbu IF, Schatzlein AG. Synthetic anticancer gene medicine exploits intrinsic antitumor activity of cationic vector to cure established tumors. Cancer Res. 2005;65:8079–8084
  6. Kukowska-Latallo JF, Bielinska AU, Johnson J, Spindler R, Tomalia DA, Baker JR. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci U S A. 1996;93:4897–4902
  7. Bielinska A, Kukowska-Latallo JF, Johnson J, Tomalia DA, Baker JR. Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers. Nucleic Acids Res. 1996;24:2176–2182
  8. Bielinska AU, Kukowska-Latallo JF, Baker JR. The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA. Biochim Biophys Acta. 1997;1353:180–190
  9. Ottaviani MF, Sacchi B. An EPR study of the interactions between starburst dendrimers and polynucleotides. Macromolecules. 1999;32:2275–2282
  10. Maruyama-Tabata H, Harada Y, Matsumura T, Satoh E, Cui F, Iwai M, et al. Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer. Gene Ther. 2000;7:53–60
  11. Wada K, Arima H, Tsutsumi T, Chihara Y, Hattori K, Hirayama F, et al. Improvement of gene delivery mediated by mannosylated dendrimer/alpha-cyclodextrin conjugates. J Control Release. 2005;104:397–413
  12. Sonawane ND, Szoka FC, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem. 2003;278:44826–44831
  13. Haensler J, Szoka FC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug Chem. 1993;4:372–379
  14. Tang MX, Redemann CT, Szoka FC. In vitro gene delivery by degraded polyamidoamine dendrimers. Bioconjug Chem. 1996;7:703–714
  15. Yoo H, Juliano RL. Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. Nucleic Acids Res. 2000;28:4225–4231
  16. Kang H, DeLong R, Fisher MH, Juliano RL. Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides. Pharm Res. 2005;22:2099–2106
  17. Lee JH, Lim YB, Choi JS, Lee Y, Kim TI, Kim HJ, et al. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency. Bioconjug Chem. 2003;14:1214–1221
  18. Choi JS, Nam K, Park JY, Kim JB, Lee JK, Park JS. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with l-arginine. J Control Release. 2004;99:445–456
  19. Kim TI, Baek JU, Zhe Bai C, Park JS. Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier. Biomaterials. 2007;28:2061–2067
  20. Zhang XQ, Wang XL, Huang SW, Zhuo RX, Liu ZL, Mao HQ, et al. In vitro gene delivery using polyamidoamine dendrimers with a trimesyl core. Biomacromolecules. 2005;6:341–350
  21. Harada A, Kawamura M, Matsuo T, Takahashi T, Kono K. Synthesis and characterization of a head-tail type polycation block copolymer as a nonviral gene vector. Bioconjug Chem. 2006;17:3–5
  22. Dennig J, Duncan E. Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. J Biotechnol. 2002;90:339–347
  23. Bielinska AU, Chen C, Johnson J, Baker JR. DNA complexing with polyamidoamine dendrimers: implications for transfection. Bioconjug Chem. 1999;10:843–850
  24. Braun CS, Vetro JA, Tomalia DA, Koe GS, Koe JG, Middaugh CR. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J Pharm Sci. 2005;94:423–436
  25. Kabanov AV, Kabanov VA. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug Chem. 1995;6:7–20
  26. Tang MX, Szoka FC. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 1997;4:823–832
  27. Li J, Piehler LT, Qin D, Baker JR, Tomalia DA. Visualization and characterization of poly(amidoamine) dendrimers by atomic force microscopy. Langmuir. 2000;16:5613–5616
  28. Lampela P, Soininen P, Urtti A, Mannisto PT, Raasmaja A. Synergism in gene delivery by small PEIs and three different nonviral vectors. Int J Pharm. 2004;270:175–184
  29. Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta. 1998;1368:276–288
  30. Zhong H, He ZG, Li Z, Li GY, Shen SR, Li XL. Studies on polyamidoamine dendrimers as efficient gene delivery vector. J Biomater Appl. 2008;22:527–544
  31. Arima H, Chihara Y, Arizono M, Yamashita S, Wada K, Hirayama F, et al. Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3). J Control Release. 2006;116:64–74
  32. Rittner K, Benavente A, Bompard-Sorlet A, Heitz F, Divita G, Brasseur R, et al. New basic membrane-destabilizing peptides for plasmid-based gene delivery in vitro and in vivo. Mol Ther. 2002;5:104–114
  33. Jevprasesphant R, Penny J, Jalal R, Attwood D, McKeown NB, D'Emanuele A. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm. 2003;252:263–266
  34. Fischer D, Li Y, Ahlemeyer B, Krieglstein J, Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 2003;24:1121–1131

 This work was financially supported by the University of Navarra Foundation (FUN) and the Government of Navarra (Department of Education).

 There are no disclosures or any conflict of interest with commercial associations.

PII: S1549-9634(09)00009-4

doi: 10.1016/j.nano.2008.12.007

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 5, Issue 3 , Pages 287-297 , September 2009

Article Tools

* Image Usage & Resolution